Clinical trials
Phase 3 Hemoglobinuria, Paroxysmal trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 4 |
| Not yet recruiting | 4 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 2 |
| Chengdu Suncadia Medicine Co., Ltd. | 2 |
| Hoffmann-La Roche | 2 |
| Nanjing Chia-tai Tianqing Pharmaceutical | 2 |
| Novartis Pharmaceuticals | 2 |
| Wuhan Createrna Science and Technology Co., Ltd | 2 |
| Bisirna Therapeutics (Suzhou) Co., Ltd. | 1 |
| Haisco Pharmaceutical Group Co., Ltd. | 1 |
| Regeneron Pharmaceuticals | 1 |
| Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemoglobinuria, Paroxysmal | 16 |
| Anemia | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.